HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Genetic susceptibility to essential hypertension: insight from angiotensinogen.

AbstractAlthough progress in the genetics of essential hypertension may seem disappointing, it has considerable potential in defining research directions that will ultimately translate into clinical practice. The hypothesis that genetic variation at the angiotensinogen locus impacts on individual susceptibility to develop essential hypertension has motivated a substantial body of research by us and many others. We examine how analyses of the mechanisms by which variation in angiotensinogen expression may contribute to disease susceptibility and may have arisen in human populations have progressed in recent years. Although the objective of personalized medicine is still in the future, a genetic hypothesis based on human variation can uniquely empower functional genomics approaches to reach such an ultimate goal.
AuthorsJean-Marc Lalouel, Andreas Rohrwasser (Affiliation: Department of Human Genetics, Eccles Institute of Human Genetics, University of Utah School of Medicine, Salt Lake City, UT 84112, USA. jml at genetics.utah.edu)
JournalHypertension (Hypertension) Vol. 49 Issue 3 Pg. 597-603 (Mar 2007) ISSN: 1524-4563 [Electronic] United States
PMID17242300 (Publication Type: Lectures, Research Support, N.I.H., Extramural)
Chemical References
  • Angiotensinogen
Topics
  • Angiotensinogen (analysis, genetics)
  • Animals
  • Disease Models, Animal
  • Gene Expression
  • Genetic Predisposition to Disease
  • Humans
  • Hypertension (genetics)
  • Mice
  • Nephrons (metabolism, physiopathology)
  • Rats
  • Renin-Angiotensin System (genetics, physiology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


Research Interface PRO additionally includes drill-down to evidence, articles by author, export to Excel, FDA Link and mobile subscription:
1 year subscription, $45.00 USD